aluates Reports

$ 0.0

Automative

Global Nausea And Vomiting Treatment Market Research Report 2026

Published Date: 2026-03-03

Report Code: QYRE-Auto-32P7025

China Nausea And Vomiting Treatment Market Report Forecast 2021 2027

BUY CHAPTERS

Global Nausea And Vomiting Treatment Market Research Report 2026

Code: QYRE-Auto-32P7025

Report

2026-03-03

Pages:120

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck& Co. Inc

Helsinn Group

Unimed Pharmaceuticals (AbbVie Inc.)

Kyowa Kirin

Sanofi

Qilu Pharma

Teva Pharmaceutical Industries Ltd

Taiji Group

Novartis

Heron Therapeutics

Mylan NV

Duchesnay Inc.

Pharmanovia

GSK

Merck& Co. Inc

Nausea And Vomiting Treatment Market Size

The global Nausea And Vomiting Treatment market was valued at US$ 6232 million in 2025 and is anticipated to reach US$ 9625 million by 2032, at a CAGR of 6.5% from 2026 to 2032.

Nausea And Vomiting Treatment Market

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.

United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.

This report delivers a comprehensive overview of the global Nausea And Vomiting Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nausea And Vomiting Treatment. The Nausea And Vomiting Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Nausea And Vomiting Treatment market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Nausea And Vomiting Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Nausea And Vomiting Treatment Market Report

Report Metric	Details
Report Name	Nausea And Vomiting Treatment Market
Accounted market size in 2025	US$ 6232 million
Forecasted market size in 2032	US$ 9625 million
CAGR	6.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Serotonin Receptor Antagonist Neurokinin NK1 Receptor Antagonist Others
Segment by Application	CINV PONV Motion Sickness Pregnancy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Pharmanovia, Mylan, Duchesnay, GSK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Nausea And Vomiting Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Nausea And Vomiting Treatment Market growing?

Ans: The Nausea And Vomiting Treatment Market witnessing a CAGR of 6.5% during the forecast period 2026-2032.

What is the Nausea And Vomiting Treatment Market size in 2032?

Ans: The Nausea And Vomiting Treatment Market size in 2032 will be US$ 9625 million.

What is the Nausea And Vomiting Treatment Market share by region?

Ans: United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.

Who are the main players in the Nausea And Vomiting Treatment Market report?

Ans: The main players in the Nausea And Vomiting Treatment Market are Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Pharmanovia, Mylan, Duchesnay, GSK

What are the Application segmentation covered in the Nausea And Vomiting Treatment Market report?

Ans: The Applications covered in the Nausea And Vomiting Treatment Market report are CINV, PONV, Motion Sickness, Pregnancy, Others

What are the Type segmentation covered in the Nausea And Vomiting Treatment Market report?

Ans: The Types covered in the Nausea And Vomiting Treatment Market report are Serotonin Receptor Antagonist, Neurokinin NK1 Receptor Antagonist, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Serotonin Receptor Antagonist

1.2.3 Neurokinin NK1 Receptor Antagonist

1.2.4 Others

1.3 Market by Application

1.3.1 Global Nausea And Vomiting Treatment Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 CINV

1.3.3 PONV

1.3.4 Motion Sickness

1.3.5 Pregnancy

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nausea And Vomiting Treatment Market Perspective (2021–2032)

2.2 Global Nausea And Vomiting Treatment Growth Trends by Region

2.2.1 Global Nausea And Vomiting Treatment Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Nausea And Vomiting Treatment Historic Market Size by Region (2021–2026)

2.2.3 Nausea And Vomiting Treatment Forecasted Market Size by Region (2027–2032)

2.3 Nausea And Vomiting Treatment Market Dynamics

2.3.1 Nausea And Vomiting Treatment Industry Trends

2.3.2 Nausea And Vomiting Treatment Market Drivers

2.3.3 Nausea And Vomiting Treatment Market Challenges

2.3.4 Nausea And Vomiting Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nausea And Vomiting Treatment Players by Revenue

3.1.1 Global Top Nausea And Vomiting Treatment Players by Revenue (2021–2026)

3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2021–2026)

3.2 Global Top Nausea And Vomiting Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Nausea And Vomiting Treatment Revenue

3.4 Global Nausea And Vomiting Treatment Market Concentration Ratio

3.4.1 Global Nausea And Vomiting Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nausea And Vomiting Treatment Revenue in 2025

3.5 Global Key Players of Nausea And Vomiting Treatment Head Offices and Areas Served

3.6 Global Key Players of Nausea And Vomiting Treatment, Products and Applications

3.7 Global Key Players of Nausea And Vomiting Treatment, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Nausea And Vomiting Treatment Breakdown Data by Type

4.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2021–2026)

4.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2027–2032)

5 Nausea And Vomiting Treatment Breakdown Data by Application

5.1 Global Nausea And Vomiting Treatment Historic Market Size by Application (2021–2026)

5.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Nausea And Vomiting Treatment Market Size (2021–2032)

6.2 North America Nausea And Vomiting Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Nausea And Vomiting Treatment Market Size by Country (2021–2026)

6.4 North America Nausea And Vomiting Treatment Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nausea And Vomiting Treatment Market Size (2021–2032)

7.2 Europe Nausea And Vomiting Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Nausea And Vomiting Treatment Market Size by Country (2021–2026)

7.4 Europe Nausea And Vomiting Treatment Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Nausea And Vomiting Treatment Market Size (2021–2032)

8.2 Asia-Pacific Nausea And Vomiting Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2021–2026)

8.4 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Nausea And Vomiting Treatment Market Size (2021–2032)

9.2 Latin America Nausea And Vomiting Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Nausea And Vomiting Treatment Market Size by Country (2021–2026)

9.4 Latin America Nausea And Vomiting Treatment Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nausea And Vomiting Treatment Market Size (2021–2032)

10.2 Middle East & Africa Nausea And Vomiting Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2021–2026)

10.4 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck & Co. Inc.

11.1.1 Merck & Co. Inc. Company Details

11.1.2 Merck & Co. Inc. Business Overview

11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Introduction

11.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.1.5 Merck & Co. Inc. Recent Development

11.2 Helsinn Group

11.2.1 Helsinn Group Company Details

11.2.2 Helsinn Group Business Overview

11.2.3 Helsinn Group Nausea And Vomiting Treatment Introduction

11.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.2.5 Helsinn Group Recent Development

11.3 Unimed Pharmaceuticals (AbbVie Inc.)

11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Details

11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview

11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Introduction

11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Development

11.4 Kyowa Kirin

11.4.1 Kyowa Kirin Company Details

11.4.2 Kyowa Kirin Business Overview

11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Introduction

11.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.4.5 Kyowa Kirin Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Nausea And Vomiting Treatment Introduction

11.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.5.5 Sanofi Recent Development

11.6 Qilu Pharma

11.6.1 Qilu Pharma Company Details

11.6.2 Qilu Pharma Business Overview

11.6.3 Qilu Pharma Nausea And Vomiting Treatment Introduction

11.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.6.5 Qilu Pharma Recent Development

11.7 Teva Pharmaceutical Industries Ltd.

11.7.1 Teva Pharmaceutical Industries Ltd. Company Details

11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Introduction

11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.8 Taiji group

11.8.1 Taiji group Company Details

11.8.2 Taiji group Business Overview

11.8.3 Taiji group Nausea And Vomiting Treatment Introduction

11.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.8.5 Taiji group Recent Development

11.9 Novartis

11.9.1 Novartis Company Details

11.9.2 Novartis Business Overview

11.9.3 Novartis Nausea And Vomiting Treatment Introduction

11.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.9.5 Novartis Recent Development

11.10 Heron Therapeutics

11.10.1 Heron Therapeutics Company Details

11.10.2 Heron Therapeutics Business Overview

11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Introduction

11.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.10.5 Heron Therapeutics Recent Development

11.11 Pharmanovia

11.11.1 Pharmanovia Company Details

11.11.2 Pharmanovia Business Overview

11.11.3 Pharmanovia Nausea And Vomiting Treatment Introduction

11.11.4 Pharmanovia Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.11.5 Pharmanovia Recent Development

11.12 Mylan

11.12.1 Mylan Company Details

11.12.2 Mylan Business Overview

11.12.3 Mylan Nausea And Vomiting Treatment Introduction

11.12.4 Mylan Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.12.5 Mylan Recent Development

11.13 Duchesnay

11.13.1 Duchesnay Company Details

11.13.2 Duchesnay Business Overview

11.13.3 Duchesnay Nausea And Vomiting Treatment Introduction

11.13.4 Duchesnay Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.13.5 Duchesnay Recent Development

11.14 GSK

11.14.1 GSK Company Details

11.14.2 GSK Business Overview

11.14.3 GSK Nausea And Vomiting Treatment Introduction

11.14.4 GSK Revenue in Nausea And Vomiting Treatment Business (2021–2026)

11.14.5 GSK Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck& Co. Inc

Helsinn Group

Unimed Pharmaceuticals (AbbVie Inc.)

Kyowa Kirin

Sanofi

Qilu Pharma

Teva Pharmaceutical Industries Ltd

Taiji Group

Novartis

Heron Therapeutics

Mylan NV

Duchesnay Inc.

Pharmanovia

GSK

Merck& Co. Inc

List of Tables

Table 1. Global Nausea And Vomiting Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Serotonin Receptor Antagonist

Table 3. Key Players of Neurokinin NK1 Receptor Antagonist

Table 4. Key Players of Others

Table 5. Global Nausea And Vomiting Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Nausea And Vomiting Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Nausea And Vomiting Treatment Market Size by Region (US$ Million), 2021–2026

Table 8. Global Nausea And Vomiting Treatment Market Share by Region (2021–2026)

Table 9. Global Nausea And Vomiting Treatment Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Nausea And Vomiting Treatment Market Share by Region (2027–2032)

Table 11. Nausea And Vomiting Treatment Market Trends

Table 12. Nausea And Vomiting Treatment Market Drivers

Table 13. Nausea And Vomiting Treatment Market Challenges

Table 14. Nausea And Vomiting Treatment Market Restraints

Table 15. Global Nausea And Vomiting Treatment Revenue by Players (US$ Million), 2021–2026

Table 16. Global Nausea And Vomiting Treatment Market Share by Players (2021–2026)

Table 17. Global Top Nausea And Vomiting Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Nausea And Vomiting Treatment Revenue, 2025

Table 18. Ranking of Global Top Nausea And Vomiting Treatment Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Nausea And Vomiting Treatment Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Nausea And Vomiting Treatment, Headquarters and Area Served

Table 21. Global Key Players of Nausea And Vomiting Treatment, Products and Applications

Table 22. Global Key Players of Nausea And Vomiting Treatment, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Nausea And Vomiting Treatment Market Size by Type (US$ Million), 2021–2026

Table 25. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2021–2026)

Table 26. Global Nausea And Vomiting Treatment Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2027–2032)

Table 28. Global Nausea And Vomiting Treatment Market Size by Application (US$ Million), 2021–2026

Table 29. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2021–2026)

Table 30. Global Nausea And Vomiting Treatment Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2027–2032)

Table 32. North America Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Nausea And Vomiting Treatment Market Size by Country (US$ Million), 2021–2026

Table 34. North America Nausea And Vomiting Treatment Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Nausea And Vomiting Treatment Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Nausea And Vomiting Treatment Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Nausea And Vomiting Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Nausea And Vomiting Treatment Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Nausea And Vomiting Treatment Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (US$ Million), 2027–2032

Table 47. Merck & Co. Inc. Company Details

Table 48. Merck & Co. Inc. Business Overview

Table 49. Merck & Co. Inc. Nausea And Vomiting Treatment Product

Table 50. Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 51. Merck & Co. Inc. Recent Development

Table 52. Helsinn Group Company Details

Table 53. Helsinn Group Business Overview

Table 54. Helsinn Group Nausea And Vomiting Treatment Product

Table 55. Helsinn Group Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 56. Helsinn Group Recent Development

Table 57. Unimed Pharmaceuticals (AbbVie Inc.) Company Details

Table 58. Unimed Pharmaceuticals (AbbVie Inc.) Business Overview

Table 59. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product

Table 60. Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 61. Unimed Pharmaceuticals (AbbVie Inc.) Recent Development

Table 62. Kyowa Kirin Company Details

Table 63. Kyowa Kirin Business Overview

Table 64. Kyowa Kirin Nausea And Vomiting Treatment Product

Table 65. Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 66. Kyowa Kirin Recent Development

Table 67. Sanofi Company Details

Table 68. Sanofi Business Overview

Table 69. Sanofi Nausea And Vomiting Treatment Product

Table 70. Sanofi Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 71. Sanofi Recent Development

Table 72. Qilu Pharma Company Details

Table 73. Qilu Pharma Business Overview

Table 74. Qilu Pharma Nausea And Vomiting Treatment Product

Table 75. Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 76. Qilu Pharma Recent Development

Table 77. Teva Pharmaceutical Industries Ltd. Company Details

Table 78. Teva Pharmaceutical Industries Ltd. Business Overview

Table 79. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product

Table 80. Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 81. Teva Pharmaceutical Industries Ltd. Recent Development

Table 82. Taiji group Company Details

Table 83. Taiji group Business Overview

Table 84. Taiji group Nausea And Vomiting Treatment Product

Table 85. Taiji group Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 86. Taiji group Recent Development

Table 87. Novartis Company Details

Table 88. Novartis Business Overview

Table 89. Novartis Nausea And Vomiting Treatment Product

Table 90. Novartis Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 91. Novartis Recent Development

Table 92. Heron Therapeutics Company Details

Table 93. Heron Therapeutics Business Overview

Table 94. Heron Therapeutics Nausea And Vomiting Treatment Product

Table 95. Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 96. Heron Therapeutics Recent Development

Table 97. Pharmanovia Company Details

Table 98. Pharmanovia Business Overview

Table 99. Pharmanovia Nausea And Vomiting Treatment Product

Table 100. Pharmanovia Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 101. Pharmanovia Recent Development

Table 102. Mylan Company Details

Table 103. Mylan Business Overview

Table 104. Mylan Nausea And Vomiting Treatment Product

Table 105. Mylan Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 106. Mylan Recent Development

Table 107. Duchesnay Company Details

Table 108. Duchesnay Business Overview

Table 109. Duchesnay Nausea And Vomiting Treatment Product

Table 110. Duchesnay Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 111. Duchesnay Recent Development

Table 112. GSK Company Details

Table 113. GSK Business Overview

Table 114. GSK Nausea And Vomiting Treatment Product

Table 115. GSK Revenue in Nausea And Vomiting Treatment Business (US$ Million), 2021–2026

Table 116. GSK Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Nausea And Vomiting Treatment Picture

Figure 2. Global Nausea And Vomiting Treatment Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Nausea And Vomiting Treatment Market Share by Type: 2025 vs 2032

Figure 4. Serotonin Receptor Antagonist Features

Figure 5. Neurokinin NK1 Receptor Antagonist Features

Figure 6. Others Features

Figure 7. Global Nausea And Vomiting Treatment Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Nausea And Vomiting Treatment Market Share by Application: 2025 vs 2032

Figure 9. CINV Case Studies

Figure 10. PONV Case Studies

Figure 11. Motion Sickness Case Studies

Figure 12. Pregnancy Case Studies

Figure 13. Others Case Studies

Figure 14. Nausea And Vomiting Treatment Report Years Considered

Figure 15. Global Nausea And Vomiting Treatment Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Nausea And Vomiting Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Nausea And Vomiting Treatment Market Share by Region: 2025 vs 2032

Figure 18. Global Nausea And Vomiting Treatment Market Share by Players in 2025

Figure 19. Global Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Nausea And Vomiting Treatment Revenue in 2025

Figure 21. North America Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Nausea And Vomiting Treatment Market Share by Country (2021–2032)

Figure 23. United States Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Nausea And Vomiting Treatment Market Share by Country (2021–2032)

Figure 27. Germany Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Nausea And Vomiting Treatment Market Share by Region (2021–2032)

Figure 35. China Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Nausea And Vomiting Treatment Market Share by Country (2021–2032)

Figure 43. Mexico Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Nausea And Vomiting Treatment Market Share by Country (2021–2032)

Figure 47. Israel Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Nausea And Vomiting Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Merck & Co. Inc. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 51. Helsinn Group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 52. Unimed Pharmaceuticals (AbbVie Inc.) Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 53. Kyowa Kirin Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 54. Sanofi Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 55. Qilu Pharma Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 56. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 57. Taiji group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 58. Novartis Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 59. Heron Therapeutics Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 60. Pharmanovia Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 61. Mylan Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 62. Duchesnay Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 63. GSK Revenue Growth Rate in Nausea And Vomiting Treatment Business (2021–2026)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anti Nausea and Vomiting Device Market Research Report 2024

Antiemetics for Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Nausea and Vomiting Healthcare Device Market Research Report 2024

Global Anti Nausea and Vomiting Band Market Research Report 2025

Global Gastroparesis Treatment Products Market Insights Forecast to 2030

Global Aprepitant Market Insights Forecast to 2030

Global Electronic Antiemetic Device Market Research Report 2024

Global Medical Electronic Antiemetic Device Market Research Report 2024

Global Household Electronic Antiemetic Device Market Research Report 2024

Chemotheraphy induced Nausea and Vomitting Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiemetic Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Watch Antiemetic Device Market Research Report 2024

OTC Anti nausea Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical Wrist Anti vomiting Device Market Research Report 2024

Global Granisetron HCl API Market Research Report 2024

Global Household Watch Antiemetic Device Market Research Report 2024

Granisetron Base Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Digestive Drugs Market Insights Forecast to 2030

Global Wearable Drug Induced Antiemetic Device Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions